Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

NCT03363269 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients

NCT02648906 ·Status: UNKNOWN ·Phase: PHASE4

Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

NCT01266525 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease

NCT02787746 ·Status: COMPLETED ·Phase: PHASE4

The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease

NCT00381381 ·Status: COMPLETED ·Phase: PHASE4

Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease

NCT01082965 ·Status: TERMINATED ·Phase: NA

Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).

NCT02695004 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects

NCT01860625 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

NCT01466088 ·Status: COMPLETED ·Phase: PHASE2

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

NCT00988598 ·Status: COMPLETED ·Phase: PHASE1

Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg

NCT02550665 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

NCT00895895 ·Status: TERMINATED ·Phase: PHASE2

A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.

NCT02178124 ·Status: COMPLETED ·Phase: PHASE1

Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease

NCT00602680 ·Status: TERMINATED ·Phase: PHASE2

Zydena on Cognitive Function of Alzheimer's Disease Patients

NCT01940952 ·Status: UNKNOWN ·Phase: PHASE3

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

NCT02955706 ·Status: COMPLETED ·Phase: PHASE4

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

NCT01327859 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)

NCT00777608 ·Status: COMPLETED ·Phase: PHASE1

Donepezil and Memantine in Moderate to Severe Alzheimer's Disease

NCT00866060 ·Status: UNKNOWN ·Phase: PHASE4

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

NCT02162251 ·Status: COMPLETED

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)

NCT06285240 ·Status: COMPLETED ·Phase: PHASE1

Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease

NCT00188812 ·Status: COMPLETED ·Phase: PHASE3

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

NCT02322021 ·Status: TERMINATED ·Phase: PHASE2